SCHEMBL4534202

SCHEMBL4534202

NP(S)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8663574 0.72
SCHEMBL31148293 0.72
SCHEMBL1450365 0.72
SCHEMBL291737 0.67
SCHEMBL1618697 0.61
SCHEMBL11677132 0.55
SCHEMBL31433057 0.55
SCHEMBL10791591 0.55
Phosphine SCHEMBL8585867 0.55
SCHEMBL11882095 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119731296-A Lubricating oil composition 引能仕株式会社 2025-03-28 CN disclosed
CN-119731295-A Lubricating oil additive composition and lubricating oil composition 引能仕株式会社 2025-03-28 CN disclosed
CN-119731294-A Lubricating oil additive composition and lubricating oil composition 引能仕株式会社 2025-03-28 CN disclosed
US-20240382610-A1 NECTIN-4 ANTIBODIES AND CONJUGATES HORIZON TECHNOLOGY FINANCE CORPORATION 2024-11-21 US disclosed
US-20240374746-A1 SIRP-ALPHA ANTIBODIES AND CONJUGATES HORIZON TECHNOLOGY FINANCE CORPORATION 2024-11-14 US disclosed
CN-118652888-A Modified double stranded RNA reagents 阿尔尼拉姆医药品有限公司 2024-09-17 CN disclosed
US-20240287528-A1 TRANSGLUTAMINASE-MEDIATED CONJUGATION HORIZON TECHNOLOGY FINANCE CORPORATION 2024-08-29 US disclosed
US-20240264142-A1 MOLECULAR DETECTION AND COUNTING USING NANOPORES ROCHE SEQUENCING SOLUTIONS INC (US) 2024-08-08 US disclosed
EP-4392076-A1 SIRP-ALPHA ANTIBODIES AND CONJUGATES Tallac Therapeutics, Inc. (US) 2024-07-03 EP disclosed
US-20240191242-A1 TRANSGLUTAMINASE-MEDIATED CONJUGATION HORIZON TECHNOLOGY FINANCE CORPORATION 2024-06-13 US disclosed
US-20130123333-A1 Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications NORTHWESTERN UNIVERSITY (US) 2013-05-16 US disclosed
US-8252756-B2 Nucleic acid functionalized nanoparticles for therapeutic applications NORTHWESTERN UNIVERSITY (US) 2012-08-28 US disclosed
US-20090209629-A1 Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications NORTHWESTERN UNIVERSITY (US) 2009-08-20 US disclosed
WO-2006138145-A1 NUCLEIC ACID FUNCTIONALIZED NANOPARTICLES FOR THERAPEUTIC APPLICATIONS NORTHWESTERN UNIVERSITY (US) 2006-12-28 WO disclosed
US-20050214772-A1 Thio modified aptamer synthetic methods and compositions BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2005-09-29 US disclosed
US-6867289-B1 Thio-modified aptamer synthetic methods and compositions BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMS (US) 2005-03-15 US disclosed
EP-1143980-A4 THIO-MODIFIED APTAMER SYNTHETIC METHODS AND COMPOSITIONS REGENTS BOARD OF (US) 2003-07-02 EP disclosed
EP-1143980-A1 THIO-MODIFIED APTAMER SYNTHETIC METHODS AND COMPOSITIONS Board of Regents, The University of Texas System (US) 2001-10-17 EP disclosed
WO-2000024404-A1 THIO-MODIFIED APTAMER SYNTHETIC METHODS AND COMPOSITIONS BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) 2000-05-04 WO disclosed
US-4025585-A INSECTICIDES, HERBICIDES CHEVRON RESEARCH COMPANY (US) 1977-05-24 US disclosed